Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
ferroheme i + H2O + acceptor
hydroxyferroheme i + reduced acceptor
ferroheme o + H2O + 2 acceptor
ferroheme a + 2 reduced acceptor
ferroheme o + H2O + acceptor
ferroheme i + reduced acceptor
ferroheme i + H2O + acceptor
hydroxyferroheme i + reduced acceptor
the enzyme catalyses the conversion of heme o to heme a by two successive hydroxylations of the methyl group at C-8, using water as the oxygen source. The first hydroxylation forms heme i, the second hydroxylation results in an unstable dihydroxymethyl group, which spontaneously dehydrates, resulting in the formyl group
-
-
?
ferroheme i + H2O + acceptor
hydroxyferroheme i + reduced acceptor
the enzyme catalyses the conversion of heme o to heme a by two successive hydroxylations of the methyl group at C-8, using water as the oxygen source. The first hydroxylation forms heme i, the second hydroxylation results in an unstable dihydroxymethyl group, which spontaneously dehydrates, resulting in the formyl group
-
-
?
ferroheme o + H2O + 2 acceptor
ferroheme a + 2 reduced acceptor
overall reaction
-
-
?
ferroheme o + H2O + 2 acceptor
ferroheme a + 2 reduced acceptor
overall reaction
-
-
?
ferroheme o + H2O + 2 acceptor
ferroheme a + 2 reduced acceptor
overall reaction. The enzyme is involved in biosynthesis of heme A, an obligatory cofactor in eukaryotic cytochrome c oxidase. The enzyme catalyses the conversion of heme o to heme a by two successive hydroxylations of the methyl group at C-8, using water as the oxygen source. The first hydroxylation forms heme i, the second hydroxylation results in an unstable dihydroxymethyl group, which spontaneously dehydrates, resulting in the formyl group of heme a
-
-
?
ferroheme o + H2O + 2 acceptor
ferroheme a + 2 reduced acceptor
overall reaction. The enzyme catalyses the conversion of heme o to heme a by two successive hydroxylations of the methyl group at C-8, using water as the oxygen source. The first hydroxylation forms heme i, the second hydroxylation results in an unstable dihydroxymethyl group, which spontaneously dehydrates, resulting in the formyl group of heme a
-
-
?
ferroheme o + H2O + 2 acceptor
ferroheme a + 2 reduced acceptor
overall reaction. The enzyme is involved in biosynthesis of heme A, an obligatory cofactor in eukaryotic cytochrome c oxidase. The enzyme catalyses the conversion of heme o to heme a by two successive hydroxylations of the methyl group at C-8, using water as the oxygen source. The first hydroxylation forms heme i, the second hydroxylation results in an unstable dihydroxymethyl group, which spontaneously dehydrates, resulting in the formyl group of heme a
-
-
?
ferroheme o + H2O + 2 acceptor
ferroheme a + 2 reduced acceptor
overall reaction. The enzyme catalyses the conversion of heme o to heme a by two successive hydroxylations of the methyl group at C-8, using water as the oxygen source. The first hydroxylation forms heme i, the second hydroxylation results in an unstable dihydroxymethyl group, which spontaneously dehydrates, resulting in the formyl group of heme a
-
-
?
ferroheme o + H2O + 2 acceptor
ferroheme a + 2 reduced acceptor
overall reaction. The enzyme is involved in biosynthesis of heme A, an obligatory cofactor in eukaryotic cytochrome c oxidase. The enzyme catalyses the conversion of heme o to heme a by two successive hydroxylations of the methyl group at C-8, using water as the oxygen source. The first hydroxylation forms heme i, the second hydroxylation results in an unstable dihydroxymethyl group, which spontaneously dehydrates, resulting in the formyl group of heme a
-
-
?
ferroheme o + H2O + 2 acceptor
ferroheme a + 2 reduced acceptor
overall reaction. The enzyme catalyses the conversion of heme o to heme a by two successive hydroxylations of the methyl group at C-8, using water as the oxygen source. The first hydroxylation forms heme i, the second hydroxylation results in an unstable dihydroxymethyl group, which spontaneously dehydrates, resulting in the formyl group of heme a
-
-
?
ferroheme o + H2O + 2 acceptor
ferroheme a + 2 reduced acceptor
overall reaction. The enzyme is involved in biosynthesis of heme A, an obligatory cofactor in eukaryotic cytochrome c oxidase. The enzyme catalyses the conversion of heme o to heme a by two successive hydroxylations of the methyl group at C-8, using water as the oxygen source. The first hydroxylation forms heme i, the second hydroxylation results in an unstable dihydroxymethyl group, which spontaneously dehydrates, resulting in the formyl group of heme a
-
-
?
ferroheme o + H2O + 2 acceptor
ferroheme a + 2 reduced acceptor
overall reaction. The enzyme catalyses the conversion of heme o to heme a by two successive hydroxylations of the methyl group at C-8, using water as the oxygen source. The first hydroxylation forms heme i, the second hydroxylation results in an unstable dihydroxymethyl group, which spontaneously dehydrates, resulting in the formyl group of heme a
-
-
?
ferroheme o + H2O + acceptor
ferroheme i + reduced acceptor
the enzyme catalyses the conversion of heme o to heme a by two successive hydroxylations of the methyl group at C-8, using water as the oxygen source. The first hydroxylation forms heme i, the second hydroxylation results in an unstable dihydroxymethyl group, which spontaneously dehydrates, resulting in the formyl group
-
-
?
ferroheme o + H2O + acceptor
ferroheme i + reduced acceptor
the enzyme catalyses the conversion of heme o to heme a by two successive hydroxylations of the methyl group at C-8, using water as the oxygen source. The first hydroxylation forms heme i, the second hydroxylation results in an unstable dihydroxymethyl group, which spontaneously dehydrates, resulting in the formyl group
-
-
?
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Brain Diseases
Phenotypic variability and mutation hotspot in COX15-related Leigh syndrome.
Cardiomyopathies
Novel mutations in COX15 in a long surviving Leigh syndrome patient with cytochrome c oxidase deficiency.
Cardiomyopathy, Hypertrophic
Analysis of Oligomerization Properties of Heme a Synthase Provides Insights into its Function in Eukaryotes.
Cardiomyopathy, Hypertrophic
Leigh syndrome associated with a novel mutation in the COX15 gene.
Cardiomyopathy, Hypertrophic
Mutations in COX10 result in a defect in mitochondrial heme A biosynthesis and account for multiple, early-onset clinical phenotypes associated with isolated COX deficiency.
Cardiomyopathy, Hypertrophic
Mutations in COX15 produce a defect in the mitochondrial heme biosynthetic pathway, causing early-onset fatal hypertrophic cardiomyopathy.
Cytochrome-c Oxidase Deficiency
Defects in the biosynthesis of mitochondrial heme c and heme a in yeast and mammals.
Cytochrome-c Oxidase Deficiency
Mutations in COX15 produce a defect in the mitochondrial heme biosynthetic pathway, causing early-onset fatal hypertrophic cardiomyopathy.
Cytochrome-c Oxidase Deficiency
Novel mutations in COX15 in a long surviving Leigh syndrome patient with cytochrome c oxidase deficiency.
Leigh Disease
Analysis of Oligomerization Properties of Heme a Synthase Provides Insights into its Function in Eukaryotes.
Leigh Disease
Functional and genetic studies demonstrate that mutation in the COX15 gene can cause Leigh syndrome.
Leigh Disease
Leigh syndrome associated with a novel mutation in the COX15 gene.
Leigh Disease
Mutations in COX10 result in a defect in mitochondrial heme A biosynthesis and account for multiple, early-onset clinical phenotypes associated with isolated COX deficiency.
Leigh Disease
Novel mutations in COX15 in a long surviving Leigh syndrome patient with cytochrome c oxidase deficiency.
Leigh Disease
Phenotypic variability and mutation hotspot in COX15-related Leigh syndrome.
Lung Neoplasms
Cox15 is a novel oncogene that required for lung cancer cell proliferation.
Mitochondrial Diseases
Phenotypic variability and mutation hotspot in COX15-related Leigh syndrome.
Neoplasms
Cox15 is a novel oncogene that required for lung cancer cell proliferation.
Neoplasms
Systematic expression analysis of the mitochondrial respiratory chain protein subunits identifies COX5B as a prognostic marker in clear cell renal cell carcinoma.
Nervous System Diseases
Analysis of Oligomerization Properties of Heme a Synthase Provides Insights into its Function in Eukaryotes.
Osteoporosis
Identification of B cells participated in the mechanism of postmenopausal women osteoporosis using microarray analysis.
Pulmonary Disease, Chronic Obstructive
Effects of exercise training on quadriceps muscle gene expression in chronic obstructive pulmonary disease.
Starvation
CtaA of Staphylococcus aureus is required for starvation survival, recovery, and cytochrome biosynthesis.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
malfunction
cox15 mutants are blocked in heme A but not heme O biosynthesis
malfunction
overexpression of a non-functional mutant causes a reduction in heme A content. This hindrance in the heme A synthesis provokes a reduction on CcO activity and, in consequence, an impairment on Trypanosoma cruzi survival, proliferation and infectivity
malfunction
-
overexpression of a non-functional mutant causes a reduction in heme A content. This hindrance in the heme A synthesis provokes a reduction on CcO activity and, in consequence, an impairment on Trypanosoma cruzi survival, proliferation and infectivity
-
metabolism
-
heme O hydroxylation, catalyzed by Cox15p is an important regulatory step
metabolism
-
the enzyme is involved in biosynthesis of heme A
metabolism
-
the enzyme is involved in biosynthesis of heme A
metabolism
the enzyme is involved in biosynthesis of heme A
metabolism
the enzyme is involved in biosynthesis of heme A, an obligatory cofactor in eukaryotic cytochrome c oxidase. The enzyme catalyses the conversion of heme o to heme a by two successive hydroxylations of the methyl group at C-8, using water as the oxygen source. The first hydroxylation forms heme i, the second hydroxylation results in an unstable dihydroxymethyl group, which spontaneously dehydrates, resulting in the formyl group of heme a
metabolism
-
the enzyme is involved in heme A biosynthesis
metabolism
-
the enzyme is required for heme A biosynthesis
metabolism
the enzyme is required for heme A biosynthesis
metabolism
-
the enzyme is involved in biosynthesis of heme A, an obligatory cofactor in eukaryotic cytochrome c oxidase. The enzyme catalyses the conversion of heme o to heme a by two successive hydroxylations of the methyl group at C-8, using water as the oxygen source. The first hydroxylation forms heme i, the second hydroxylation results in an unstable dihydroxymethyl group, which spontaneously dehydrates, resulting in the formyl group of heme a
-
metabolism
-
the enzyme is involved in biosynthesis of heme A
-
metabolism
-
the enzyme is required for heme A biosynthesis
-
physiological function
the COX15 protein is essential for the assembly of yeast cytochrome oxidase
physiological function
the enzyme is required for starvation survival, recovery, and cytochrome biosynthesis
physiological function
-
the enzyme is required for starvation survival, recovery, and cytochrome biosynthesis
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
DELTA211-217
Bacillus subtilis LMT20R is deleted for the ctaA gene and, therefore, completely blocked in heme A synthesis. Plasmid pH216MS is obtained from plasmid pH216M (encoding the mutant CtaA-H216M) and carries a 21 bp deletion in ctaA. The CtaADELTA211-217 variant encoded by pH216MS is active in heme A synthesis and supports assembly of normal levels of cytochrome caa3
E57A
heme content of the mutant enzyme is 62% compared to wild-type enzyme
E57A/H216A
heme content of the mutant enzyme is 28% compared to wild-type enzyme
E57A/H278A
heme content of the mutant enzyme is 42% compared to wild-type enzyme
E57Q
heme content of the mutant enzyme is 65% compared to wild-type enzyme
H123A
heme content of the mutant enzyme is 74% compared to wild-type enzyme
H123Q
heme content of the mutant enzyme is 64% compared to wild-type enzyme
H216A
heme content of the mutant enzyme is 22% compared to wild-type enzyme
H216A-H278A
heme content of the mutant enzyme is 5% compared to wild-type enzyme
H216L
no detectable activity
H216M/DELTA211-217
Bacillus subtilis LMT20R is deleted for the ctaA gene and, therefore, completely blocked in heme A synthesis. Plasmid pH216MS is obtained from plasmid pH216M (encoding the mutant CtaA-H216M) and carries a 21 bp deletion in ctaA. The CtaADELTA211-217 variant encoded by pH216MS is active in heme A synthesis and supports assembly of normal levels of cytochrome caa3
H216Q
heme content of the mutant enzyme is 33% compared to wild-type enzyme
H216Q-H278Q
heme content of the mutant enzyme is 6% compared to wild-type enzyme
H278A
heme content of the mutant enzyme is 56% compared to wild-type enzyme
H278C
heme content of the mutant enzyme is 14% compared to wild-type enzyme
H278Q
heme content of the mutant enzyme is 15% compared to wild-type enzyme
H60A
heme content of the mutant enzyme is 74% compared to wild-type enzyme
H60A/H123A
heme content of the mutant enzyme is 88% compared to wild-type enzyme
H60L
no detectable activity
H60Q
heme content of the mutant enzyme is 65% compared to wild-type enzyme
H60Q-H123Q
heme content of the mutant enzyme is 83% compared to wild-type enzyme
Q103A
heme content of the mutant enzyme is 82% compared to wild-type enzyme
Q257A
heme content of the mutant enzyme is 78% compared to wild-type enzyme
R217A
heme content of the mutant enzyme is 84% compared to wild-type enzyme
R217Q
heme content of the mutant enzyme is 89% compared to wild-type enzyme
R61A
heme content of the mutant enzyme is 77% compared to wild-type enzyme
R61Q
heme content of the mutant enzyme is 79% compared to wild-type enzyme
W39A
heme content of the mutant enzyme is 84% compared to wild-type enzyme
DELTA211-217
-
Bacillus subtilis LMT20R is deleted for the ctaA gene and, therefore, completely blocked in heme A synthesis. Plasmid pH216MS is obtained from plasmid pH216M (encoding the mutant CtaA-H216M) and carries a 21 bp deletion in ctaA. The CtaADELTA211-217 variant encoded by pH216MS is active in heme A synthesis and supports assembly of normal levels of cytochrome caa3
-
E57A
-
heme content of the mutant enzyme is 62% compared to wild-type enzyme
-
H123A
-
heme content of the mutant enzyme is 74% compared to wild-type enzyme
-
H123L
-
inactive enzyme, stable proteins containing heme O and heme B
-
H123M
-
inactive enzyme, stable proteins containing heme O and heme B
-
H216L
-
no detectable activity
-
H216M/DELTA211-217
-
Bacillus subtilis LMT20R is deleted for the ctaA gene and, therefore, completely blocked in heme A synthesis. Plasmid pH216MS is obtained from plasmid pH216M (encoding the mutant CtaA-H216M) and carries a 21 bp deletion in ctaA. The CtaADELTA211-217 variant encoded by pH216MS is active in heme A synthesis and supports assembly of normal levels of cytochrome caa3
-
H278Q
-
heme content of the mutant enzyme is 15% compared to wild-type enzyme
-
H60A
-
heme content of the mutant enzyme is 74% compared to wild-type enzyme
-
H60L
-
no detectable activity
-
H60Q
-
heme content of the mutant enzyme is 65% compared to wild-type enzyme
-
R217W
-
mutations of COX15 causing single amino acid conversions associated with fatal infantile hypertrophic cardiomyopathy and the neurological disorder Leigh syndrome results in impaired catalytic function, and the mutation affects oligomeric properties of the enzyme. The mutations affects protein folding and heme binding
S344P
-
mutations of COX15 causing single amino acid conversions associated with fatal infantile hypertrophic cardiomyopathy and the neurological disorder Leigh syndrome results in impaired stability. The mutations affect protein folding and heme binding
H129A
overexpression of the non-functional TcCox15 mutants causes a negative effect over heme A synthesis, affecting the function of the CcO complex and proliferation of epimastigotes
H206A
overexpression of the non-functional TcCox15 mutants causes a negative effect over heme A synthesis, affecting the function of the CcO complex and proliferation of epimastigotes
H307A
overexpression of the non-functional TcCox15 mutants causes a negative effect over heme A synthesis, affecting the function of the CcO complex and proliferation of epimastigotes
H129A
-
overexpression of the non-functional TcCox15 mutants causes a negative effect over heme A synthesis, affecting the function of the CcO complex and proliferation of epimastigotes
-
H206A
-
overexpression of the non-functional TcCox15 mutants causes a negative effect over heme A synthesis, affecting the function of the CcO complex and proliferation of epimastigotes
-
H307A
-
overexpression of the non-functional TcCox15 mutants causes a negative effect over heme A synthesis, affecting the function of the CcO complex and proliferation of epimastigotes
-
additional information
-
mutations in COX15 repress heme O synthesis and have a dominant effect when combined with other mutations
C191A/C197A
low activity
C191A/C197A
the heme content is reduced to a half of the wild-type level
C35A/C42A
no detectable activity
C35A/C42A
heme content of the mutant enzyme is 77% compared to wild-type enzyme
H123L
no detectable activity
H123L
inactive enzyme, stable proteins containing heme O and heme B
H123M
no detectable activity
H123M
inactive enzyme, stable proteins containing heme O and heme B
H216M
low activity
H216M
heme content of the mutant enzyme is 37% compared to wild-type enzyme
H216M
the H216M variant binds the enzyme substrate heme O, probably with methionine as an axial ligand, but is defective in heme A synthesis and accumulates a mono-hydroxylated reaction intermediate, heme I
H216M
the variant has a decreased heme A synthase activity. It contains heme B, heme O, and heme I, as well as trace amounts of heme A
H278M
low activity
H278M
heme content of the mutant enzyme is 40% compared to wild-type enzyme
H60M
low activity
H60M
the mutant enzyme contains heme B and heme A at levels comparable to that of wild-type enzyme
H216M
-
the H216M variant binds the enzyme substrate heme O, probably with methionine as an axial ligand, but is defective in heme A synthesis and accumulates a mono-hydroxylated reaction intermediate, heme I
-
H216M
-
the variant has a decreased heme A synthase activity. It contains heme B, heme O, and heme I, as well as trace amounts of heme A
-
H60M
-
low activity
-
H60M
-
the mutant enzyme contains heme B and heme A at levels comparable to that of wild-type enzyme
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Hegg, E.
Biosynthesis and regulation of the heme a biosynthetic pathway
ACS Symp. Ser.
1012
31-46
2009
Bacillus subtilis, Cereibacter sphaeroides
-
brenda
Merli, M.L.; Cirulli, B.A.; Menendez-Bravo, S.M.; Cricco, J.A.
Heme A synthesis and CcO activity are essential for Trypanosoma cruzi infectivity and replication
Biochem. J.
474
2315-2332
2017
Trypanosoma cruzi (V5BC58), Trypanosoma cruzi, Trypanosoma cruzi Dm28c (V5BC58)
brenda
Brown, K.; Allan, B.; Do, P.; Hegg, E.
Identification of novel hemes generated by heme A synthase Evidence for two successive monooxygenase reactions
Biochemistry
41
10906-10913
2002
Bacillus subtilis (P12946), Bacillus subtilis, Bacillus subtilis 168 (P12946)
brenda
Brown, B.M.; Wang, Z.; Brown, K.R.; Cricco, J.A.; Hegg, E.L.
Heme O synthase and heme A synthase from Bacillus subtilis and Rhodobacter sphaeroides interact in Escherichia coli
Biochemistry
43
13541-13548
2004
Bacillus subtilis, Cereibacter sphaeroides (Q3IXW9), Cereibacter sphaeroides, Cereibacter sphaeroides ATCC 17023 (Q3IXW9)
brenda
Brown, K.; Brown, B.; Hoagland, E.; Mayne, C.; Hegg, E.
Heme A synthase does not incorporate molecular oxygen into the formyl group of heme A
Biochemistry
43
8616-8624
2004
Bacillus subtilis (P12946), Bacillus subtilis 168 (P12946)
brenda
Morrison, M.; Cricco, J.; Hegg, E.
The biosynthesis of heme O and heme A is not regulated by copper
Biochemistry
44
12554-12563
2005
Bacillus subtilis, Saccharomyces cerevisiae, Cereibacter sphaeroides (Q3IXW9), Cereibacter sphaeroides, Cereibacter sphaeroides ATCC 17023 (Q3IXW9)
brenda
Hederstedt, L.
Heme A biosynthesis
Biochim. Biophys. Acta
1817
920-927
2012
Aeropyrum pernix, Saccharomyces cerevisiae, Halobacterium salinarum, Schizosaccharomyces pombe, Bacillus subtilis (P12946), Bacillus subtilis 168 (P12946)
brenda
Sakamoto, J.; Hayakawa, A.; Uehara, T.; Noguchi, S.; Sone, N.
Cloning of Bacillus stearothermophilus ctaA and heme a synthesis with the ctaA protein produced in Escherichia coli
Biosci. Biotechnol. Biochem.
63
96-103
1999
Geobacillus stearothermophilus (P94346), Geobacillus stearothermophilus
brenda
Barros, M.H.; Carlson, C.G.; Glerum, D.M.; Tzagoloff, A.
Involvement of mitochondrial ferredoxin and Cox15p in hydroxylation of heme O
FEBS Lett.
492
133-138
2001
Saccharomyces cerevisiae (P40086), Saccharomyces cerevisiae
brenda
Barros, M.; Tzagoloff, A.
Regulation of the heme A biosynthetic pathway in Saccharomyces cerevisiae
FEBS Lett.
516
119-123
2002
Saccharomyces cerevisiae
brenda
Lewin, A.; Hederstedt, L.
Compact archaeal variant of heme A synthase
FEBS Lett.
580
5351-5356
2006
Aeropyrum pernix (Q9YBA3), Aeropyrum pernix, Aeropyrum pernix ATCC 700893 (Q9YBA3)
brenda
Lewin, A.; Hederstedt, L.
Promoted evolution of a shortened variant of heme A synthase in the membrane of Bacillus subtilis
FEBS Lett.
582
1330-1334
2008
Bacillus subtilis (P12946), Bacillus subtilis, Bacillus subtilis 168 (P12946)
brenda
Buchensky, C.; Almirn, P.; Mantilla, B.; Silber, A.; Cricco, J.
The Trypanosoma cruzi proteins TcCox10 and TcCox15 catalyze the formation of heme A in the yeast Saccharomyces cerevisiae
FEMS Microbiol. Lett.
312
133-141
2010
Trypanosoma cruzi (Q4DTN9), Trypanosoma cruzi
brenda
Svensson, B.; Hederstedt, L.
Bacillus subtilis CtaA is a heme-containing membrane protein involved in heme A biosynthesis
J. Bacteriol.
176
6663-6671
1994
Bacillus subtilis
brenda
Clements, M.; Watson, S.; Poole, R.; Foster, S.
CtaA of Staphylococcus aureus is required for starvation survival, recovery, and cytochrome biosynthesis
J. Bacteriol.
181
501-507
1999
Staphylococcus aureus (Q2G2C0), Staphylococcus aureus, Staphylococcus aureus NCTC 8325 (Q2G2C0)
brenda
Hederstedt, L.; Lewin, A.; Throne-Holst, M.
Heme A synthase enzyme functions dissected by mutagenesis of Bacillus subtilis CtaA
J. Bacteriol.
187
8361-8369
2005
Bacillus subtilis (P12946), Bacillus subtilis, Bacillus subtilis 168 (P12946)
brenda
Mogi, T.
Probing structure of heme A synthase from Bacillus subtilis by site-directed mutagenesis
J. Biochem.
145
625-633
2009
Bacillus subtilis (P12946), Bacillus subtilis, Bacillus subtilis 168 (P12946)
brenda
Glerum, D.M.; Muroff, I.; Jin, C.; Tzagoloff, A.
COX15 codes for a mitochondrial protein essential for the assembly of yeast cytochrome oxidase
J. Biol. Chem.
272
19088-19094
1997
Saccharomyces cerevisiae (P40086), Saccharomyces cerevisiae
brenda
Barros, M.; Nobrega, F.; Tzagoloff, A.
Mitochondrial ferredoxin is required for heme a synthesis in Saccharomyces cerevisiae
J. Biol. Chem.
277
9997-10002
2002
Saccharomyces cerevisiae
brenda
Wang, Z.; Wang, Y.; Hegg, E.L.
Regulation of the heme A biosynthetic pathway differential regulation of heme A synthase and heme O synthase in Saccharomyces cerevisiae
J. Biol. Chem.
284
839-847
2009
Saccharomyces cerevisiae, Saccharomyces cerevisiae W303a
brenda
Swenson, S.; Cannon, A.; Harris, N.J.; Taylor, N.G.; Fox, J.L.; Khalimonchuk, O.
Analysis of oligomerization properties of heme a synthase provides insights into its function in eukaryotes
J. Biol. Chem.
291
10411-10425
2016
Saccharomyces cerevisiae
brenda